ABSTRACT
Three dipolar aprotic solvents were designed to possess high dipolarity and low toxicity: N,N,N',N'-tetrabutylsuccindiamide (TBSA), N,N'-diethyl-N,N'-dibutylsuccindiamide (EBSA), and N,N'-dimethyl-N,N'-dibutylsuccindiamide (MBSA). They were synthesized catalytically by using a K60 silica catalyst in a solventless system. Their water immiscibility stands out as an unusual and useful property for dipolar aprotic solvents. They were tested in a model Heck reaction, metal-organic framework syntheses, and a selection of polymer solubility experiments in which their performances were found to be comparable to traditional solvents. Furthermore, MBSA was found to be suitable for the production of an industrially relevant membrane from polyethersulfone. An integrated approach involving inâ silico analysis based on available experimental information, prediction model outcomes and read across data, as well as a panel of inâ vitro reporter gene assays covering a broad range of toxicological endpoints was used to assess toxicity. These inâ silico and inâ vitro tests suggested no alarming indications of toxicity in the new solvents.
ABSTRACT
To derive an acute TTC threshold, the correlation between Allowable Daily Intakes (ADIs, chronic values) and Acute Reference Doses (ARfDs) of pesticides evaluated in the EU was investigated and their distributions were compared. The correlation between ARfDs and ADIs was significant (p = 0.01), but weak (r(2) = 0.051). Consequently, using this approach to derive acute TTC values does not seem valid. Therefore, the distributions of ARfDs and ADIs were compared directly, in order to extrapolate from chronic to acute TTC values. This comparison made for the combined Cramer structural class II and III pesticides showed a ratio ARfD/ADI of approximately 3 at the fifth percentile of the distributions. Based on these results, it is justified to propose a TTC for acute effects for Cramer III substances by multiplying the Cramer class III TTC threshold of 90 µg/person/day with a factor 3. This leads to an acute TTC threshold based on the Munro dataset for Cramer class III substances of 270 µg/person/day.
Subject(s)
Environmental Exposure/adverse effects , Food Contamination , Pesticides/adverse effects , Databases, Factual , Dose-Response Relationship, Drug , Humans , Models, Statistical , No-Observed-Adverse-Effect Level , Risk Assessment , Threshold Limit Values , Toxicity TestsABSTRACT
Previously we showed a battery consisting of CALUX transcriptional activation assays, the ReProGlo assay, and the embryonic stem cell test, and zebrafish embryotoxicity assay as 'apical' tests to correctly predict developmental toxicity for 11 out of 12 compounds, and to explain the one false negative [7]. Here we report on applying this battery within the context of grouping and read across, put forward as a potential tool to fill data gaps and avoid animal testing, to distinguish in vivo non- or weak developmental toxicants from potent developmental toxicants within groups of structural analogs. The battery correctly distinguished 2-methylhexanoic acid, monomethyl phthalate, and monobutyltin trichloride as non- or weak developmental toxicants from structurally related developmental toxicants valproic acid, mono-ethylhexyl phthalate, and tributyltin chloride, respectively, and, therefore, holds promise as a biological verification model in grouping and read across approaches. The relevance of toxicokinetic information is indicated.
Subject(s)
Animal Testing Alternatives , Teratogens/toxicity , Toxicity Tests/methods , Animals , Cell Line , Cells, Cultured , Embryo, Nonmammalian/drug effects , Embryonic Stem Cells/drug effects , Genes, Reporter , Humans , Mice , Receptors, Estrogen/metabolism , Reproduction , Teratogens/classification , Teratogens/pharmacokinetics , Toxicokinetics , Zebrafish/embryologyABSTRACT
Quantitative Property Property Relationships (QPPRs) for human and rat blood:air partition coefficients (PBAs) have been derived, based on vapour pressure (Log(VP)), the octanol:water partition coefficient (Log(K(OW))) and molecular weight (MW), using partial least squares multilinear modelling. These parameters are all included in the standard data to be submitted under REACH. The chemical dataset consisted of volatile organic chemicals, principally aliphatic hydrocarbons, benzene derivatives with one aromatic ring, and ethers, with and without halogen atoms. Other chemicals represented were cyclic hydrocarbons and carbonic acid esters. Separate rat and human models were derived, as well as mixed ones. Log(VP) and Log(K(OW)) contributed most to the prediction of Log(PBA) in the three-parameter model, while the contribution of MW was relatively small. Still, the three-parameter model differed significantly from the two-parameter model and performed better. Its performance was comparable to that of models published in public literature, which are based on more complex molecular parameters or on measured olive:oil air and saline/water:air partition coefficients. Since, based on the available data for humans, rats, mice, dogs and rabbits, existence of interspecies differences of PBAs cannot be clearly excluded, the use of separate models for each species is advisable. Concluding, the three-parameter human model Log(PBA)=6.96-1.04 Log(VP)-0.533 Log(K(OW))-0.00495MW and the three-parameter rat model 6.16-0.888 Log(VP)-0.521 Log(K(OW))-0.00201MW provide robust and reliable models for predicting PBA values of volatile organic chemicals using commonly available chemical properties of molecules.
Subject(s)
Air , Blood , Models, Biological , Volatile Organic Compounds/chemistry , 1-Octanol/chemistry , Animals , Humans , Hydrocarbons/chemistry , Molecular Weight , Quantitative Structure-Activity Relationship , Rats , Vapor Pressure , Water/chemistryABSTRACT
Most QSARs for dermal absorption predict the permeability coefficient, K(p), of a molecule, which is valid for infinite dose conditions. In practice, dermal exposure mostly occurs under finite dose conditions. Therefore, a simple model to predict finite dose dermal absorption from infinite dose data (K(p) and lag time) and the stratum corneum/water partition coefficient (K(SC,W)) was developed. To test the model, a series of in vitro dermal absorption experiments was performed under both infinite and finite dose conditions using acetic acid, benzoic acid, bis(2-ethylhexyl)phthalate, butoxyethanol, cortisone, decanol, diazinone, 2,4-dichlorophenol, ethacrynic acid, linolenic acid, octylparaben, oleic acid, propylparaben, salicylic acid and testosterone. For six substances, the predicted relative dermal absorption was not statistically different from the measured value. For all other substances, measured absorption was overpredicted by the model, but most of the overpredictions were still below the European default absorption value. In conclusion, our finite dose prediction model provides a useful and cost-effective estimate of dermal absorption, to be used in risk assessment for non-volatile substances dissolved in water at non-irritating concentrations.
Subject(s)
Databases, Factual , Models, Biological , Skin Absorption/physiology , Skin/metabolism , Adult , Dose-Response Relationship, Drug , Female , Hormones/chemistry , Hormones/pharmacokinetics , Humans , In Vitro Techniques , Lipids/chemistry , Lipids/pharmacokinetics , Middle Aged , Organic Chemicals/chemistry , Organic Chemicals/pharmacokinetics , Prognosis , Quantitative Structure-Activity Relationship , Risk AssessmentABSTRACT
Quantification of skin absorption is an essential step in reducing the uncertainty of dermal risk assessment. Data from literature indicate that the relative dermal absorption of substances is dependent on dermal loading. Therefore, an internal exposure calculated with absorption data determined at a dermal loading not comparable to the actual loading may lead to a wrong assessment of the actual health risk. To investigate the relationship between dermal loading and relative absorption in a quantitative manner, 138 dermal publicly available absorption experiments with 98 substances were evaluated (87 in vitro, 51 in vivo; molecular weight between 40 and 950, logP between -5 and 13), with dermal loading ranging mostly between 0.001 and 10mg/cm(2). In 87 experiments (63%) an inverse relationship was observed between relative dermal absorption and dermal loading, with an average decrease of factor 33+/-69. Known skin irritating and volatile substances less frequently showed an inverse relationship between dermal loading and relative absorption.
Subject(s)
Skin Absorption , Skin Irritancy Tests/methods , Animals , Humans , Inorganic Chemicals/pharmacokinetics , Inorganic Chemicals/toxicity , Organic Chemicals/pharmacokinetics , Organic Chemicals/toxicity , Risk AssessmentABSTRACT
The in vitro dermal absorption kinetics of didecyldimethylammonium chloride (DDAC) was studied after single and multiple exposure. In addition, the influence of biocidal formulations on the absorption of DDAC was investigated. Following dermal exposure to DDAC in aqueous solution, less than 0.5% of the applied dose reached the receptor fluid after 48h. The apparent permeability coefficient (K(p)) was 5+/-1cm/h x 10(-6) for concentrations <12.5mg/mL, and 12+/-3 cm/h x 10(-6) for concentrations >or=12.5 mg/mL, suggesting that DDAC decreases the skin barrier function. DDAC distributed readily into the stratum corneum, but the dermis appeared to be the main barrier for DDAC penetration. Multiple dosing of DDAC increased its flux across the skin, when applied in high concentrations (>11 mg/mL). However, the amount of DDAC reaching the receptor fluid remained low (<1% over a 48 h period). Selected biocidal formulations tended to reduce DDAC skin absorption. The degree of reduction appeared to be correlated to the amount of aldehydes present. Based on the comparison of the distribution of DDAC in full-thickness skin and epidermal membranes, we conclude that approximately one-third of the DDAC measured in the full-thickness membranes resides in the dermis. As a reasonable worst case assumption, this fraction could be considered systemically available when estimating the daily systemic body burden of DDAC.
Subject(s)
Disinfectants/administration & dosage , Quaternary Ammonium Compounds/pharmacokinetics , Skin Absorption/drug effects , Administration, Cutaneous , Cells, Cultured , Chemistry, Pharmaceutical/methods , Disinfectants/pharmacokinetics , Humans , Kinetics , Permeability , Quaternary Ammonium Compounds/therapeutic use , Tissue DistributionABSTRACT
The dermal route of exposure is important in worker exposure to biocidal products. Many biocidal active substances which are used on a daily basis may decrease the barrier function of the skin to a larger extent than current risk assessment practice addresses, due to possible skin effects of repeated exposure. The influence of repeated and single exposure to representative biocidal active substances on the skin barrier was investigated in vitro. The biocidal active substances selected were alkyldimethylbenzylammonium chloride (ADBAC), boric acid, deltamethrin, dimethyldidecylammonium chloride (DDAC), formaldehyde, permethrin, piperonyl butoxide, sodium bromide, and tebuconazole. Of these nine compounds, only the quaternary ammonium chlorides ADBAC and DDAC had a clear and consistent influence on skin permeability of the marker compounds tritiated water and [(14)C]propoxur. For these compounds, repeated exposure increased skin permeability more than single exposure. At high concentrations the difference between single and repeated exposure was quantitatively significant: repeated exposure to 300 mg/L ADBAC increased skin permeability two to threefold in comparison to single exposure. Therefore, single and repeated exposure to specific biocidal products may significantly increase skin permeability, especially when used undiluted.